Moxibustion for shingles and post-herpetic neuralgia: what the research says
What meta-analyses report on acupuncture plus moxibustion for acute herpes zoster and on moxibustion for post-herpetic neuralgia, including the 'firm conclusion not possible' verdicts and safety considerations on broken skin.
Short answer: shingles (herpes zoster) and its lingering nerve pain, post-herpetic neuralgia (PHN), are treated with moxibustion in China, often combined with acupuncture, pricking or cupping. Reviews report possible benefit for pain and skin outcomes, but say the evidence is limited [2]. For PHN specifically, a review concluded that a firm conclusion is not possible [3].
Shingles, especially near the eye, needs prompt medical treatment. Do not apply moxa to broken or blistered skin. CDC guidance emphasizes early diagnosis and antiviral care [1]. Evidence summary only.
What reviews report
| Condition | Source | Finding | Caveat |
|---|---|---|---|
| Acute herpes zoster | Acupuncture plus moxibustion review, 2017 [2] | Nine trials, 945 adults; one trial reported a small pain-score difference versus pharmacotherapy | Authors say clinical significance of that pain difference is uncertain; study quantity and methods limit confidence |
| Post-herpetic neuralgia (PHN) | Moxibustion review, 2021 [3] | Pooled pain and composite response measures favoured moxibustion in the included studies | Authors could not draw a firm efficacy or safety conclusion because of methodological weaknesses and heterogeneity |
| PHN | Acupuncture and moxibustion and cupping review, 2021 [4] | Authors reported lower pain scores than with conventional medicine in included comparisons | A three-method package cannot identify the effect of moxa alone; check for overlap with other reviews |
| Acute herpes zoster | Joss-stick moxibustion plus pricking and cupping RCT, 2017 [5] | Earlier pain easing was reported than with conventional medicine | Composite total effective rates were 29/33 versus 29/34, not significantly different |
| Herpes zoster | Five-method economic evaluation, 2012 [6] | No statistically significant difference in day-ten clinical effect among five groups; cost ratios varied | Cost and treatment context are specific to the trial setting, not a current product price or buying recommendation |
Acute rash and later nerve pain are separate questions
Acute herpes zoster involves a viral rash and pain. Post-herpetic neuralgia is pain that persists after the acute episode; studies using those two labels should not be added into a single treatment claim. CDC describes shingles as reactivation of varicella-zoster virus and advises early diagnosis and antiviral treatment, with particular urgency when the cornea could be affected [1]. A technique paper about managing pain does not establish antiviral activity or replace that treatment pathway.
The 2017 acute-zoster review examined acupuncture plus moxibustion. Although nine studies involved 945 adults, the abstract’s numerical pain difference of −8.25 mm on a visual analogue scale came from one study, and the authors explicitly said its clinical significance was unknown. It is misleading to describe all 945 participants as evidence for that one effect estimate, or to credit moxibustion alone [2]. The 2017 trial added pricking and cupping to a joss-stick moxibustion protocol. It reported a shorter time before pain started to ease, but the overall composite response rates did not differ significantly between groups [5].
For PHN, one review pooled studies of moxibustion methods including medicated thread and thunder-fire approaches. Despite favourable pooled numbers, the authors’ bottom-line judgment was that methodological quality and heterogeneity prevented a firm conclusion on benefit or safety [3]. Another pooled analysis combines acupuncture, moxibustion and cupping. Its positive wording concerns a combined intervention; the review cannot assign a fraction of the result to any one component [4]. These are not contradictory trials of a single standardised moxa product.
Questions to take from a source to a decision
Ask whether the study is about an active rash or persistent nerve pain, and whether moxa is used alone or alongside needles, pricking, cupping and medicines. Check the comparator, pain scale, follow-up and adverse-event reporting. The economic paper compared five treatment strategies over ten days in its own health-system setting; its cost-effectiveness ratios are not a current price for a retail moxa stick or a reason to choose one [6]. This source map helps readers interpret research and procurement claims. It does not recommend self-treatment of shingles.
Skin safety
A UK review of moxa smoke recommended stronger warnings against using moxa on broken skin [7], and clinic handouts advise not to use moxa on open wounds or inflamed skin [8]. Shingles lesions are broken, inflamed skin. Trials were run by practitioners in clinics, not at home.
The warning applies to the contact between an active lesion and a heated or burning material; it does not become safe because a product is marketed as “smokeless.” Anyone with suspected shingles, particularly a rash near the eye, needs the clinical treatment decision made first [1]. Product format, packaging and marketing language cannot resolve that medical decision.
Related pages
FAQ: related questions
Is moxibustion used for shingles?
A review of nine adult acute-shingles trials examined acupuncture plus moxibustion, not moxa alone, and reported possible pain and skin-outcome benefits with methodological limits. A separate review of post-herpetic neuralgia could not reach a firm efficacy or safety conclusion. Shingles needs prompt clinical assessment and antiviral treatment.
Is it safe to use moxa on shingles blisters?
Do not put a burning product on broken, blistered or inflamed skin. A moxa-smoke safety paper explicitly called for stronger warnings about broken skin, while CDC guidance stresses early antiviral care for shingles, especially where the eye may be affected.
Sources for this page
- CDC Clinical Overview of Shingles (Herpes Zoster). www.cdc.gov/shingles/hcp/clinical-overview/index.html
- Coyle et al. Acupuncture plus moxibustion for herpes zoster: A systematic review and meta-analysis of randomized controlled trials. Dermatol Ther 2017. pubmed.ncbi.nlm.nih.gov/28338265/
- Wu et al. Efficacy and Safety of Moxibustion for Postherpetic Neuralgia: A Systematic Review and Meta-Analysis. Front Neurol 2021. pubmed.ncbi.nlm.nih.gov/34512502/
- Zhou et al. Acupuncture and moxibustion combined with cupping for the treatment of post-herpetic neuralgia: A meta-analysis. Medicine (Baltimore) 2021. pubmed.ncbi.nlm.nih.gov/34397828/
- Ye et al. [Effect of joss stick moxibustion combined with pricking and cupping for acute herpes zoster and its mechanism of analgesia]. Zhongguo Zhen Jiu 2017. pubmed.ncbi.nlm.nih.gov/29354993/
- Li et al. Economic evaluation of treating herpes zoster with various methods of acupuncture and moxibustion. J Tradit Chin Med 2012. pubmed.ncbi.nlm.nih.gov/22594116/
- Wheeler et al. Does the burning of moxa (Artemisia vulgaris) in traditional Chinese medicine constitute a health hazard?. Acupunct Med 2009. pubmed.ncbi.nlm.nih.gov/19369189/
- Smokeless Moxa home instructions (Olympic Acupuncture). olympicacupuncture.com/acu/wellness-tips/smokeless-moxa/
Last reviewed: . Editorial note: this guide re-edits published sources; it does not provide medical advice or new research.
Moxa Sourcing
Need a sourcing brief?
Moxa Sourcing helps brands and clinics compare product formats and samples, plan private-label packaging and coordinate export handoff. Start with your market, quantity and packaging goals.
What details help us start?
Share the format, market, quantity, packaging, destination and expected timing.
